Who
Neil Lindsay Berkley
CFO & Chief Business Officer
Company insider
Files Form 4 as: CFO & Chief Business Officer, Alector.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $439K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2025
- Last trade
- 14 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month. 2 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 15 Oct 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —44,567 at $0.00 | filing |
| 14 Oct 2026filed 15 Oct 2026 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $78K29,251 at $2.66 | filing |
| 3 Sep 2026filed 4 Sep 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $78K29,251 at $2.66 | filing |
| 2 Jun 2026filed 3 Jun 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $38K19,360 at $1.97 | filing |
| 2 Jun 2026filed 3 Jun 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $38K19,360 at $1.97 | filing |
| —filed 13 Mar 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —54,600 at $0.00 | filing |
| —filed 13 Mar 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —54,600 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $63K29,649 at $2.12 | filing |
| 2 Mar 2026filed 3 Mar 2026 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $63K29,649 at $2.12 | filing |
| 3 Dec 2025filed 3 Dec 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $42K37,261 at $1.12 | filing |
| 10 Nov 2025filed 12 Nov 2025 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 10 Nov 2025filed 12 Nov 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 2 Sep 2025filed 4 Sep 2025 | ALEC AlectorBiotechnology | SEC FORM 4 Sold | $40K15,842 at $2.50 | filing |
| 1 Jul 2025filed 1 Jul 2025 | ALEC Alectoroption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
News
Alector (NASDAQ:ALEC) CFO Neil Lindsay Berkley Sells 29,251 Sharesthemarketsdaily.com · 5 Sep 2026Alector (NASDAQ: ALEC) prices shares at a 7.3% premium in stock saleALEC · dailypolitical.com · 18 Oct 2026Alector Maps Brain-Delivery Pipeline for Alzheimer's, Parkinson's TherapiesALEC · dailypolitical.com · 13 Oct 2026
1 headline in the last 90 days name Neil Lindsay Berkley; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.